Camp4 Therapeutics Corp (CAMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 12-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -25,028 | -12,452 | -49,291 | -36,301 | -44,192 |
| Depreciation Amortization | 860 | 436 | 1,678 | 1,243 | 878 |
| Accounts payable and accrued liabilities | -59 | 985 | N/A | -965 | N/A |
| Other Working Capital | -2,939 | -413 | -1,269 | -957 | 1,704 |
| Other Operating Activity | 2,585 | 301 | 4,727 | 4,608 | 3,067 |
| Operating Cash Flow | $-24,581 | $-11,143 | $-44,155 | $-32,372 | $-38,543 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -178 | -15 | -678 | -435 | -4,025 |
| Investing Cash Flow | $-178 | $-15 | $-678 | $-435 | $-4,025 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 706 | N/A |
| Debt Repayment | -408 | -204 | N/A | -354 | N/A |
| Common Stock Issued | 2 | 2 | N/A | 12 | N/A |
| Other Financing Activity | -608 | 0 | 301 | 0 | 100,157 |
| Financing Cash Flow | $-1,014 | $-202 | $301 | $364 | $100,157 |
| Beginning Cash Position | 40,004 | 40,004 | 84,536 | 84,536 | 26,947 |
| End Cash Position | 14,231 | 28,644 | 40,004 | 52,093 | 84,536 |
| Net Cash Flow | $-25,773 | $-11,360 | $-44,532 | $-32,443 | $57,589 |
| Free Cash Flow | |||||
| Operating Cash Flow | -24,581 | -11,143 | -44,155 | -32,372 | -38,543 |
| Capital Expenditure | -178 | -15 | N/A | -435 | N/A |
| Free Cash Flow | -24,759 | -11,158 | -44,155 | -32,807 | -38,543 |